Production in Escherichia coli of extracellular Serratia spp. hydrolases |
| We claim: 1. A method of producing an extracellular hydrolytic Serratia spp. enzyme selected from ... |
|
Modular assembly of antibody genes, antibodies prepared thereby and use |
| What is claimed is: 1. A polynucleotide molecule encoding an immunoglobulin fragment, said ... |
|
Cytoplasmic bacteriophage display system |
| The present invention relates, in one aspect, to a display vector comprising DNA encoding a portion ... |
|
Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions |
| AND ADVANTAGES According to the present invention, a method of diagnosing and determining the ... |
|
Polyvalent display libraries |
| I. General The present invention is directed to inter alia two related but self-sufficient ... |
|
Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| OF THE INVENTION A. Definitions Amino Acid Residue: An amino acid formed upon chemical digestion (... |
|
Pharmaceutical and diagnostic business systems and methods |
| Improved business methods, devices, and systems for utilizing genetic information are provided. A... |
|
Method of differential display of exposed mRNA by RT/PCR |
| We claim: 1. A method of comparing the presence or level of individual mRNA molecules in two or ... |
|
Methods of screening for compounds that derepress or increase telomerase activity |
| We claim: 1. Method for screening for a telomerase derepression agent, the method comprising the ... |
|
|
Antisense modulation of stat3 expression
| Details |
Inventors: Karras, James G.;
Assignee: Isis Pharmaceuticals Inc. (Carlsbad, CA)
Primary Examiner: Guzo; David
Assistant Examiner: Wang; Andrew
Attorney, Agent or Firm: Law Offices of Jane Massey Licata
Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 are provided. |
|
DETAILED DESCRIPTION OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/or constitutive activation of STAT3 is associated with a number of inflammatory diseases and cancers. As such, this DNA-binding protein represents an attractive target for treatment of such diseases. In particular, modulation of the expression of STAT3 may be useful for the treatment of diseases such as rheumatoid arthritis, breast cancer, brain cancer, leukemias and lymphomas. The present invention employs antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid molecules encoding STAT3, ultimately modulating the amount of STAT3 produced. This is accomplished by providing oligonucleotides which specifically hybridize with nucleic acids, preferably mRNA, encoding STAT3. This relationship between an antisense compound such as an oligonucleotide and its complementary nucleic acid target, to which it hybridizes, is commonly referred to as "antisense". "Targeting" an oligonucleotide to a chosen nucleic acid target, in the context of this invention, is a multistep process. The process usually begins with identifying a nucleic acid sequence whose function is to be modulated. This may be, as examples, a cellular gene (or mRNA made from the gene) whose expression is associated with a particular disease state, or a foreign nucleic acid from an infectious agent. In the present invention, the targets are nucleic acids encoding STAT3; in other words, a gene encoding STAT3, or mRNA expressed from the STAT3 gene. mRNA which encodes STAT3 is presently the preferred target. The targeting process also includes determination of a site or sites within the nucleic acid sequence for the antisense interaction to occur such that modulation of gene expression will result. In accordance with this invention, persons of ordinary skill in the art will understand that messenger RNA includes not only the information to encode a protein using the three letter genetic code, but also associated ribonucleotides which form a region known to such persons as the 5'-untranslated region, the 3'-untranslated region, the 5' cap region and intron/exon junction ribonucleotides
|
| Related patents |
|
|
Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which could overcome the above-mentioned drawbacks which are usually ...
|
|
|
Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering particles of a powdered therapeutic agent across skin tissue of a mammalian ...
|
|
|
Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG repeat sequences of telomeres. Such TRFs comprise two key domains: a ...
|
|
|
Protease-activated receptor PAR4 (ZCHEMR2)
What is claimed is: 1. An isolated polynucleotide molecule that encodes a polypeptide comprising amino acid residues 48 to 78 of SEQ ID NO:2. 2. The isolated ...
|
|
|
Systemic drug delivery compositions comprising a polycationi substance
I claim: 1. A method of systemically delivering a pharmaceutically effective amount of a pharmacologically active compound to a mammal comprising: administering to a ...
|
|
|
Nucleic acid-containing composition, its preparation and use
We claim: 1. A composition comprising a deoxyribonucleic acid and a cationic oligopeptide that forms secondary structures, wherein the oligopeptide corresponds to the ...
|
|
|
Peptide-enhanced cationic lipid transfections
OF THE INVENTION The present invention provides improved methods for transfecting eukaryotic cells with nucleic acids by employing peptides or modified peptides in ...
|
|
|
Controlled release formulations coated with aqueous dispersions of acrylic polymers
It is therefore an object of the present invention to provide a controlled release formulation of a substrate comprising an active agent, e.g. a therapeutically active ...
|
|
|
Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
What is claimed is: 1. A compound having the formula I: ##STR5## wherein, R.sub.1 is OH, O--R.sub.3, C--R.sub.3, halo, NHR.sub.4, ONHR.sub.5 or ON.dbd.R.sub.6, wherein R....
|
|
|
Substituted indazole-O-glucosides
OF THE INVENTION All diabetics, regardless of their genetic and environmental backgrounds, have in common an apparent lack of insulin or inadequate insulin function. B...
|
|
|